Skip to main content
Caplight Logo









Superstring Capital Management

Superstring Capital Management

New York City, New Yorksuperstringcap.com

Overview

Superstring Capital Management is a New York-based investment firm dedicated to the healthcare sector, with a focus on public and private investments in pharmaceutical, biotechnology, medtech, and healthcare services companies globally.

Year Founded

2019

Portfolio Companies

9

Investments

Superstring Capital Management investments
CompanyDateStageLead
Elpiscience BiopharmaceuticalsMay 2021Series CCo-investor
Nurotron Biotechnology Co., Ltd.Sep 2020StrategicCo-investor
ReCode TherapeuticsOct 2021Series BCo-investor
Shoreline BiosciencesNov 2021Series BCo-investor
SironaxAug 2022Series BCo-investor
Book a demo to see all 9 portfolio companies

For institutional investors. Book with your work email.

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Superstring Capital Management based?

Superstring Capital Management is headquartered in New York City, New York, United States.

When was Superstring Capital Management founded?

Superstring Capital Management was founded in 2019.

How many portfolio companies does Superstring Capital Management have?

Superstring Capital Management has 9 portfolio companies in Caplight's dataset.

What are some companies in Superstring Capital Management's portfolio?

Portfolio companies visible on Caplight include Elpiscience Biopharmaceuticals, Nurotron Biotechnology Co., Ltd., ReCode Therapeutics, Shoreline Biosciences, Sironax.

What was Superstring Capital Management's most recent investment shown here?

Superstring Capital Management's most recent investment in this portfolio sample was in Sironax in 2022.

What sectors does Superstring Capital Management focus on?

Superstring Capital Management focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.

What company stages does Superstring Capital Management focus on?

Superstring Capital Management typically invests at the Mid stage.

What is Superstring Capital Management's AUM?

Superstring Capital Management's assets under management are estimated between $218.3M and $218.3M.

Firmographic Details

HeadquartersNew York City, New York
Year Founded2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?